PQNT vs HRTS overlap
PQNT and HRTS overlap 4.6% by weight, across 5 shared holdings.
Pick 2 to 4 ETFs.
Top shared holdings
| Holding | PQNT | HRTS | Overlap |
|---|---|---|---|
| Astrazeneca PLCAZN | 2.03% | 4.00% | 2.03% |
| Novartis AG-REGNOVN | 1.36% | 3.38% | 1.36% |
| Chugai Pharma CoCHGCF | 0.61% | 1.33% | 0.61% |
| TEVA Pharm-ADRTEVA | 0.29% | 2.06% | 0.29% |
| NOVO Nordisk-BNOVOB | 0.28% | 5.24% | 0.28% |
Overlap by weight adds up the smaller weight of each holding the funds share, so 100% means identical portfolios. Long securities only: derivatives and cash vehicles are left out. Sources: PQNT, SEC Form N-PORT, June 30, 2026; HRTS, SEC Form N-PORT, May 31, 2026.
Largest institutions holding both
No 13F filer reports holding both.
This compares who owns the funds, not what the funds hold. From SEC Form 13F, for managers with $100M+ in US securities.
Who owns them: PQNT institutional holders, HRTS institutional holders.
Frequently asked questions
How much do PQNT and HRTS overlap?
4.6% by weight, with 5 holdings in common, using holdings for PQNT as of June 30, 2026 and HRTS as of May 31, 2026. The largest shared position is AZN.
Do institutions hold both PQNT and HRTS?
0 Form 13F filers report positions in both, out of 21 that report either one.
How is overlap by weight worked out?
For each holding the two funds share, take the smaller of the two weights, then add those up. Identical portfolios score 100%.